AWM
GNOM icon

Avior Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Avior Wealth Management’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-196
Closed -$9.51K – 1624
2023
Q2 		$9.51K Buy
196
+1
+0.5% +$50 ﹤0.01% 1033
2023
Q1 		$9.62K Buy
+195
New +$10K ﹤0.01% 1059

Other funds holding GNOM

Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
MWAM
Manhattan West Asset Management Los Angeles, California $511M AUM 18.81% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Avior Wealth Management's GNOM Position: Q3 2023 in Review

Avior Wealth Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2023, closing a stake of 196 shares — an estimated $9.51K sold.

Avior Wealth Management first reported a position in GNOM in Q1 2023 and held it in 2 quarters. The position peaked at $9.62K in Q1 2023. 63 funds tracked by Wall St. Rank hold GNOM as of Q3 2023.

  • Avior Wealth Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2023 after selling out during the quarter.
  • Avior Wealth Management sold 196 Global X Genomics & Biotechnology ETF shares in Q3 2023, an estimated $9.51K.
  • Avior Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q1 2023 and held it in 2 quarters.
  • Avior Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $9.62K in Q1 2023.
  • 63 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2023.

Based on Avior Wealth Management's 13F filing for Q3 2023, filed 17 Oct 2023.